However, our prediction model incorporated new parameters such as blood albumin level, and non-invasive markers of hepatic fibrosis such as nonalcoholic fatty liver disease, fibrosis score, and fibrosis-4 index. This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.